News
Article
Pharmaceutical Technology
Is Global Regulatory Gridlock Slowing Modernization?
Author(s):
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.
PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology. Fewer pharmaceutical companies even do “technology scouting” today.
Maik Jornitz, who chaired the aging facilities taskforce during its first year, discusses challenges and what is required for change.
Download Pharmaceutical Technology’s
2016 Quality Throughout the Supply Chain eBook.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
